Publication | Closed Access

Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia

Exploratory AnalysisPsychoactive DrugPsychiatryPsychotic DisorderMedicinePsychopharmacologySchizophreniaNeuropsychiatryNeuropharmacologySocial SciencesPharmacotherapyNeuroscienceBiological PsychiatryMetabotropic Glutamate 2/3PharmacologyPsychopathology